Stay updated with breaking news from Lyra therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lyra Therapeutics (NASDAQ:LYRA – Get Rating) and Adynxx (OTCMKTS:ADYX – Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability. Valuation & Earnings This table compares Lyra Therapeutics and Adynxx’s gross […] ....
/PRNewswire/ Lyra Therapeutics, Inc. (NASDAQ: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,. ....
Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Rating) – Cantor Fitzgerald issued their FY2023 earnings per share (EPS) estimates for Lyra Therapeutics in a note issued to investors on Monday, June 6th. Cantor Fitzgerald analyst L. Chen forecasts that the company will post earnings of ($1.68) per share for the year. Cantor Fitzgerald has a “Overweight” […] ....